Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India

DCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.

from Latest News https://ift.tt/30lPdXb